PL00CID-10: Y40-Y59Capitulo 23

Drogas, medicamentos ou substâncias biológicas associadas a lesões ou danos no uso terapêutico

Drugs, medicaments or biological substances associated with injury or harm in therapeutic use

Correspondencia Principal

Y40-Y59

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

Mapeamento oficial OMS do release 2026-01.

Outras Correspondencias CID-10

Y40

Systemic antibiotics

Y40.0

Penicillins

Y40.1

Cefalosporins and other beta-lactam antibiotics

Y40.2

Chloramphenicol group

Y40.3

Macrolides

Y40.4

Tetracyclines

Y40.5

Aminoglycosides

Y40.6

Rifamycins

Y40.7

Antifungal antibiotics, systemically used

Y40.8

Other systemic antibiotics

Y40.9

Systemic antibiotic, unspecified

Y41

Other systemic anti-infectives and antiparasitics

Y41.0

Sulfonamides

Y41.1

Antimycobacterial drugs

Y41.2

Antimalarials and drugs acting on other blood protozoa

Y41.3

Other antiprotozoal drugs

Y41.4

Anthelminthics

Y41.5

Antiviral drugs

Y41.8

Other specified systemic anti-infectives and antiparasitics

Y41.9

Systemic anti-infective and antiparasitic, unspecified

Y42

Hormones and their synthetic substitutes and antagonists, not elsewhere classified

Y42.0

Glucocorticoids and synthetic analogues

Y42.1

Thyroid hormones and substitutes

Y42.2

Antithyroid drugs

Y42.3

Insulin and oral hypoglycaemic [antidiabetic] drugs

Y42.4

Oral contraceptives

Y42.5

Other estrogens and progestogens

Y42.6

Antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified

Y42.7

Androgens and anabolic congeners

Y42.8

Other and unspecified hormones and their synthetic substitutes

Y42.9

Other and unspecified hormone antagonists

Y43

Primarily systemic agents

Y43.0

Antiallergic and antiemetic drugs

Y43.1

Antineoplastic antimetabolites

Y43.2

Antineoplastic natural products

Y43.3

Other antineoplastic drugs

Y43.4

Immunosuppressive agents

Y43.5

Acidifying and alkalizing agents

Y43.6

Enzymes, not elsewhere classified

Y43.8

Other primarily systemic agents, not elsewhere classified

Y43.9

Primarily systemic agent, unspecified

Y44

Agents primarily affecting blood constituents

Y44.0

Iron preparations and other anti-hypochromic-anaemia preparations

Y44.1

Vitamin B 12 , folic acid and other anti-megaloblastic-anaemia preparations

Y44.2

Anticoagulants

Y44.3

Anticoagulant antagonists, vitamin K and other coagulants

Y44.4

Antithrombotic drugs [platelet-aggregation inhibitors]

Y44.5

Thrombolytic drugs

Y44.6

Natural blood and blood products

Y44.7

Plasma substitutes

Y44.9

Other and unspecified agents affecting blood constituents

Y45

Analgesics, antipyretics and anti-inflammatory drugs

Y45.0

Opioids and related analgesics

Y45.1

Salicylates

Y45.2

Propionic acid derivatives

Y45.3

Other nonsteroidal anti-inflammatory drugs [NSAID]

Y45.4

Antirheumatics

Y45.5

4-Aminophenol derivatives

Y45.8

Other analgesics and antipyretics

Y45.9

Analgesic, antipyretic and anti-inflammatory drug, unspecified

Y46

Antiepileptics and antiparkinsonism drugs

Y46.0

Succinimides

Y46.1

Oxazolidinediones

Y46.2

Hydantoin derivatives

Y46.4

Iminostilbenes

Y46.5

Valproic acid

Y46.6

Other and unspecified antiepileptics

Y46.7

Antiparkinsonism drugs

Y46.8

Antispasticity drugs

Y47

Sedatives, hypnotics and antianxiety drugs

Y47.0

Barbiturates, not elsewhere classified

Y47.1

Benzodiazepines

Y47.2

Cloral derivatives

Y47.3

Paraldehyde

Y47.4

Bromine compounds

Y47.5

Mixed sedatives and hypnotics, not elsewhere classified

Y47.8

Other sedatives, hypnotics and antianxiety drugs

Y47.9

Sedative, hypnotic and antianxiety drug, unspecified

Y48

Anaesthetics and therapeutic gases

Y48.0

Inhaled anaesthetics

Y48.1

Parenteral anaesthetics

Y48.2

Other and unspecified general anaesthetics

Y48.3

Local anaesthetics

Y48.4

Anaesthetic, unspecified

Y48.5

Therapeutic gases

Y49

Psychotropic drugs, not elsewhere classified

Y49.0

Tricyclic and tetracyclic antidepressants

Y49.1

Monoamine-oxidase-inhibitor antidepressants

Y49.2

Other and unspecified antidepressants

Y49.3

Phenothiazine antipsychotics and neuroleptics

Y49.4

Butyrophenone and thioxanthene neuroleptics

Y49.5

Other antipsychotics and neuroleptics

Y49.6

Psychodysleptics [hallucinogens]

Y49.7

Psychostimulants with abuse potential

Y49.8

Other psychotropic drugs, not elsewhere classified

Y49.9

Psychotropic drug, unspecified

Y50

Central nervous system stimulants, not elsewhere classified

Y50.0

Analeptics

Y50.1

Opioid receptor antagonists

Y50.2

Methylxanthines, not elsewhere classified

Y50.8

Other central nervous system stimulants

Y50.9

Central nervous system stimulant, unspecified

Y51

Drugs primarily affecting the autonomic nervous system

Y51.0

Anticholinesterase agents

Y51.1

Other parasympathomimetics [cholinergics]

Y51.2

Ganglionic blocking drugs, not elsewhere classified

Y51.3

Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified

Y51.4

Predominantly alpha-adrenoreceptor agonists, not elsewhere classified

Y51.5

Predominantly beta-adrenoreceptor agonists, not elsewhere classified

Y51.6

Alpha-adrenoreceptor antagonists, not elsewhere classified

Y51.7

Beta-adrenoreceptor antagonists, not elsewhere classified

Y51.8

Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified

Y51.9

Other and unspecified drugs primarily affecting the autonomic nervous system

Y52

Agents primarily affecting the cardiovascular system

Y52.0

Cardiac-stimulant glycosides and drugs of similar action

Y52.1

Calcium-channel blockers

Y52.2

Other antidysrhythmic drugs, not elsewhere classified

Y52.3

Coronary vasodilators, not elsewhere classified

Y52.4

Angiotensin-converting-enzyme inhibitors

Y52.5

Other antihypertensive drugs, not elsewhere classified

Y52.6

Antihyperlipidaemic and antiarteriosclerotic drugs

Y52.7

Peripheral vasodilators

Y52.8

Antivaricose drugs, including sclerosing agents

Y52.9

Other and unspecified agents primarily affecting the cardiovascular system

Y53

Agents primarily affecting the gastrointestinal system

Y53.0

Histamine H 2 -receptor antagonists

Y53.1

Other antacids and anti-gastric-secretion drugs

Y53.2

Stimulant laxatives

Y53.3

Saline and osmotic laxatives

Y53.4

Other laxatives

Y53.5

Digestants

Y53.6

Antidiarrhoeal drugs

Y53.7

Emetics

Y53.8

Other agents primarily affecting the gastrointestinal system

Y53.9

Agent primarily affecting the gastrointestinal system, unspecified

Y54

Agents primarily affecting water-balance and mineral and uric acid metabolism

Y54.0

Mineralocorticoids

Y54.1

Mineralocorticoid antagonists [aldosterone antagonists]

Y54.2

Carbonic-anhydrase inhibitors

Y54.3

Benzothiadiazine derivatives

Y54.4

Loop [high-ceiling] diuretics

Y54.5

Other diuretics

Y54.6

Electrolytic, caloric and water-balance agents

Y54.7

Agents affecting calcification

Y54.8

Agents affecting uric acid metabolism

Y54.9

Mineral salts, not elsewhere classified

Y55

Agents primarily acting on smooth and skeletal muscles and the respiratory system

Y55.0

Oxytocic drugs

Y55.1

Skeletal muscle relaxants [neuromuscular blocking agents]

Y55.2

Other and unspecified agents primarily acting on muscles

Y55.3

Antitussives

Y55.4

Expectorants

Y55.5

Anti-common-cold drugs

Y55.6

Antiasthmatics, not elsewhere classified

Y55.7

Other and unspecified agents primarily acting on the respiratory system

Y56

Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs

Y56.0

Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified

Y56.1

Antipruritics

Y56.2

Local astringents and local detergents

Y56.3

Emollients, demulcents and protectants

Y56.4

Keratolytics, keratoplastics and other hair treatment drugs and preparations

Y56.5

Ophthalmological drugs and preparations

Y56.6

Otorhinolaryngological drugs and preparations

Y56.7

Dental drugs, topically applied

Y56.8